Committees

• Robert Moritz, USA (Chair)
• Ruth Birner-Gruenberger, Austria (Co-Chair)

MEMBERS - EASTERN REGION

Subhra Chakraborty, India

Laura Dagley, Australia

Hosseini Salekdeh, Iran

Frank Schmidt, Qtar

Melanie White, Australia

Tadashi Yamamoto, Japan

Shamshad Zarina, Pakistan

MEMBERS - CENTRAL REGION

Adhari AlZaabi, Oman

Nicolai Bache, Denmark

Concha Gil, Spain

Magnus Palmblad, The Netherlands

Elena Ponomarenko, Russia

Paola Roncada, Italy

Yves Vandenbrouck, France

MEMBERS - WESTERN REGION

Ralph A. Bradshaw, USA

Sergio Encarnacion-Guevara, Mexico

Catherine Fenselau, USA

Yansheng Liu, USA

Hannes Rost, Canada

Birgit Schilling, USA

Pierre Thibault, Canada

Susan Weintraub, USA

The  Education  and  Training Committee shall assemble programs which include workshops, courses, tutorials, etc., that may contribute to the professional growth and scientific awareness of Members.

ETC members are expected to: 

1. Attend ETC’s monthly meeting and be an active participant 
2. Participate in efforts to raise visibility and/or financial support for ETC 
3. Each member needs to find at least one consultant and propose/lead at least one activity in one year - identify areas for improvement
4. Participate in the organization of th annual HUPO pre congress training course(s) 
5. Contribute to HUPO’s monthly HUPOST newsletter and news items documenting ETC community updates and trends in funding, services, research and more

Ben Collins, PhD (United Kingdom)

Since 2019 Ben Collins is a Reader (equiv. Assoc. Prof.) in the School of Biological Sciences, Queen’s University of Belfast, UK. His research focuses on broadly on 3 topics: (i) method development and applications in data independent acquisition mass spectrometry; (ii) method development and applications in the analysis of protein interaction networks and protein complexes; and (iii) applications of these strategies in host-pathogen biology and innate immunity. Ben Collins’s PhD was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. He moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold, where his research focused on the application of quantitative interaction proteomics in signaling and the development of DIA/SWATH mass spectrometry. Following this Ben Collins was a Group Leader and SNF Ambizione Fellow at IMSB, ETH Zurich with a focus on applying methods developed as a postdoc to relevant problems in host-pathogen biology.

Blandine Chazarin, PhD (United States)

Blandine CHAZARIN is currently postdoctoral scientist in Jennifer Van Eyk lab at Cedars-Sinai Medical Center in Los Angeles (CA, USA). Previously she studied biology at Paul Sabatier University (Toulouse, France) prior advanced training in proteomics and mass spectrometry at Lille 1 University (Lille, France). She obtained a PhD using mass spectrometry to better understand hibernating brown bear physiology to path the way of therapeutic against muscle atrophy at LSMBO (Strasbourg, France). She is the former president of the youth club of the proteomic French Society and organized yearly meeting dedicated to young scientists in proteomics. Now, she is involved in postdoctoral scientist society at Cedars-Sinai and developed single cell proteomic approach applied to cardiac cells proteome analysis.

Brian Searle, PhD (United States)

Brian Searle is an Assistant Professor at the Ohio State University Medical Center in the Department of Biomedical Informatics and a member of the Pelotonia Institute for Immuno-Oncology (PIIO). Brian received his chemistry BA at Reed College in 2001. In 2004, he co-founded Proteome Software with Mark Turner and Dr. Ashley McCormack to produce and distribute cutting-edge data analysis software for proteomicists. In 2014, he returned to academia to earn his PhD with Dr. Michael MacCoss at University of Washington, where he developed methods to detect and quantify proteins and phosphosites using mass spectrometry. His lab at PIIO spans the intersection of proteomics, mass spectrometry, bioinformatics, and technology development to study human genetic variation in the backdrop of cancer.

Deepti Jaiswal Kundu, PhD (United Kingdom)

Deepti Jaiswal Kundu, works as a Scientific Curator at EMBL-EBI, Cambridge, UK. Before joining EMBL-EBI, she studied botany, psychology, and bioinformatics in India, before doing a PhD in Cheminformatics in the Czech Republic. After successfully defending her thesis in 2015 Deepti Jaiswal Kundu moved to Cambridge, UK and took a break of briefly 2 years to have daughter. She joined EBI in 2018. As a Scientific Curator, Deepti Jaiswal Kundu is responsible to check and validate new datasets submitted to the PRoteomics IDEntifications Database (PRIDE) - the world’s largest public database dedicated to mass spectrometry-based proteomics. Furthermore, she curates the datasets for further reanalysis and integration to other bioinformatic resources in EBI.

Giuseppe Palmisano, PhD (Brazil)

Dr. Giuseppe Palmisano is currently a Professor at the Department of Parasitology, University of São Paulo, São Paulo, Brazil. He obtained his Ph.D. degree in mitochondrial physiopathology in 2008 from University of Bari under the supervision of Prof. Sergio Papa and then completed a postdoctoral fellowship at the University of Southern Denmark, Odense, under the supervision of Prof. Martin R. Larsen, developing methods for PTMs analysis in different biological samples. His current area of research is method development and application of proteomics to parasite infections (Chagas disease, Leishmaniasis and Placental Malaria) with a particular focus on regulatory mechanisms of PTMs-mediated cellular signals.

Justyna Fert-Bober, PhD (United States)

I am an Assistant Professor at Cedars-Sinai Heart Institute, and my research is focused on molecular and cellular mechanisms of heart failure (HF) in general population and in the immunopathogenesis of heart disease in the rheumatoid arthritis (RA) patient. I have a broad background in biochemistry, with specific training and expertise in proteomics and mass spectrometry and secondary immunology research. I am a pioneer in the understanding of arginine deiminases and protein citrullination’s contribution to neo-antigens production. My lab is interested in targeting the citrullinated proteins associated with the HF disease and finding the functional significance at least, in a subset of biologically important modifiable cardiac proteins. I claim that cardiac specific citrullinated proteins yield neo-antigens production and can become additional targets in epitope spreading of autoimmune responses. This will allow to create new diagnostics and prognostic tests for clinical use.

Teck Yew Low, PhD (Malaysia)

Dr Teck Yew Low is an associate professor and senior research fellow located at the UKM Medical Molecular Biology Institute (UMBI) which is affiliated to the National University of Malaysia (UKM), leading the cancer proteomics and metabolomics group. Before that, he worked at Netherlands Proteomics Centre (NPC) in Utrecht University in the Netherlands. His research interests include bridging (phospho)proteomics with clinics and cancer proteogenomics.

Qingsong Lin, PhD (Singapore)

Qingsong Lin is a Principal Research Fellow (Research Associate Professor) of the Department of Biological Sciences, National University of Singapore (NUS).  He is the Director of the Protein and Proteomics Centre (PPC), NUS.  Besides, he is the President of the Singapore Society for Mass Spectrometry (SSMS) since 2017.  His expertise lies in applications of mass spectrometry in proteins and proteomics, extended to other biomolecules.  His research interests are mainly in disease biomarker discovery and disease mechanism, drug target identification and mechanism of action studies, as well as the application of mass spectrometry and quantitative proteomics technologies to address various biological questions.

Tiannan Guo, PhD (China)

Tiannan Guo received training of clinical medicine (1999-2006) in Tongji Medical College, Huazhong University of Science and Technology, and learned biology (2001-2005) in Wuhan University, before he moved to Singapore for PhD training in cancer proteomics (2008-2012) in the laboratories of Dr. Newman Sze in Nanyang Technological University and Dr. Oi Lian Kon in National Cancer Centre Singapore. In 2012, Tiannan started his postdoctoral training in the laboratory of Dr. Ruedi Aebersold in ETH Zurich. Tiannan moved to Sydney as the Scientific Director of ProCan, group leader of Cancer Proteome, Children’s Medical Research Institute, and the conjoint senior lecturer in The University of Sydney Medical School, in March 2017. Tiannan joined the Westlake Institute for Advanced Studies, Westlake University in August 2017 as a Tenure Track Assistant Professor. He is the director of iMarker lab at Westlake Laboratory in 2020, and an associate faculty member of Center for Infectious Disease Research and Research Center for Industries of the Future at Westlake University. His research focuses on proteomic technological development and applications in precision medicine.

Yansheng Liu, PhD (United States)

Yansheng Liu is an Assistant Professor in the Department of Pharmacology at Yale University School of Medicine. He is also a group leader in quantitative proteomics at the Yale Cancer Biology Institute. Dr. Liu received his Ph.D. in Biomedical Sciences from the Chinese Academy of Sciences in 2011. He then completed a 6.5-year post-doctoral training in the laboratory of Dr. Ruedi Aebersold at ETH Zurich, Switzerland. Dr. Liu joined the faculty at Yale in December 2017. The Liu Lab has particular research interests in protein post-translational diversity (modification and turnover), cancer aneuploidy, and cell signaling transduction. The Liu Lab additionally aims to contribute to the development of multiplexed, high-throughput data-independent acquisition mass spectrometry (DIA-MS) technique.

The Nomination Committee shall consist of not less than three (3) and not more than seven (7) individuals (including at least one (1) Councilor). Members of the Nomination Committee shall be elected or appointed, as the case may be, at the annual meeting of the Council. Meetings of the Nomination Committee shall occur at least sixty-seven (67) days prior to the election of Councilors at each annual meeting of Members. The slate of candidates for Councilor offered by the Nomination Committee shall be approved by the Executive Committee not less than sixty (60) days prior to the election.  The Nomination Committee shall obtain written agreement from each candidate, make nomination recommendations and submit a list of candidates along with a short biographical sketch of each candidate to the Executive Committee for approval. The Nomination Committee shall exercise any other powers and duties as the Executive Committee may determine.

The Publications Committee shall interact with the scientific journals and the scientists in the field of proteomics and shall establish and promote the vision of the Corporation with respect to standards in publications related to proteomics. The Publications Committee shall oversee the Website and other electronic bases (e.g., Twitter) established for sharing HUPO news and information with Members and the public.